Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13,170 | $10,735 | $10,606 | $11,420 |
| % Growth | 22.7% | 1.2% | -7.1% | – |
| Cost of Goods Sold | $3,412 | $2,992 | $2,889 | $2,271 |
| Gross Profit | $9,758 | $7,743 | $7,717 | $7,844 |
| % Margin | 74.1% | 72.1% | 72.8% | 68.7% |
| R&D Expenses | $1,834 | $1,909 | $1,808 | $2,119 |
| G&A Expenses | $0 | -$2,185 | $0 | $0 |
| SG&A Expenses | $2,291 | $2,630 | $2,222 | $1,242 |
| Sales & Mktg Exp. | $0 | $4,506 | $0 | $0 |
| Other Operating Expenses | $2,010 | $1,730 | $1,402 | $1,426 |
| Operating Expenses | $6,135 | $6,269 | $5,432 | $4,787 |
| Operating Income | $3,623 | $1,474 | $2,285 | $1,185 |
| % Margin | 27.5% | 13.7% | 21.5% | 10.4% |
| Other Income/Exp. Net | -$115 | -$7 | -$85 | -$115 |
| Pre-Tax Income | $3,508 | $1,467 | $2,200 | $1,070 |
| Tax Expense | $680 | $230 | $481 | $190 |
| Net Income | $2,802 | $3,940 | $1,872 | $683 |
| % Margin | 21.3% | 36.7% | 17.7% | 6% |
| EPS | 2.3 | 3.19 | 1.52 | 0.4 |
| % Growth | -27.9% | 109.9% | 280% | – |
| EPS Diluted | 2.27 | 3.19 | 1.52 | 0.4 |
| Weighted Avg Shares Out | 1,218 | 1,234 | 1,234 | 1,249 |
| Weighted Avg Shares Out Dil | 1,234 | 1,234 | 1,234 | 1,254 |
| Supplemental Information | – | – | – | – |
| Interest Income | $114 | $76 | $86 | $37 |
| Interest Expense | $227 | $87 | $213 | $96 |
| Depreciation & Amortization | $479 | $378 | $399 | $209 |
| EBITDA | $4,214 | $1,889 | $2,770 | $563 |
| % Margin | 32% | 17.6% | 26.1% | 4.9% |